Alison Kulick
Overview
Explore the profile of Alison Kulick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roddy T, McLaren D, Chen Y, Xie D, Dunn K, Kulick A, et al.
Eur J Pharmacol
. 2014 Apr;
740:410-6.
PMID: 24769414
Inhibition of cholesteryl ester transfer protein (CETP) has been vigorously pursued as a potential therapy to treat patients who are at an elevated risk for coronary artery disease. Anacetrapib, a...
2.
Herath K, Bhat G, Miller P, Wang S, Kulick A, Andrews-Kelly G, et al.
Anal Biochem
. 2011 May;
415(2):197-9.
PMID: 21596013
Protein synthesis can be estimated by measuring the incorporation of a labeled amino acid into a proteolytic peptide. Although prelabeled amino acids are typically administered, recent studies have tested (2)H(2)O;...
3.
Previs S, Mahsut A, Kulick A, Dunn K, Andrews-Kelly G, Johnson C, et al.
J Lipid Res
. 2011 Apr;
52(7):1420-8.
PMID: 21498887
The advantages of using (2)H(2)O to quantify cholesterol synthesis include i) homogeneous precursor labeling, ii) incorporation of (2)H via multiple pathways, and iii) the ability to perform long-term studies in...
4.
Treonze K, Alves K, Fischer P, Hagmann W, Hora D, Kulick A, et al.
Vet Immunol Immunopathol
. 2009 Mar;
130(1-2):79-87.
PMID: 19250687
The purpose of this study was to characterize the alpha(4)beta(1) receptor (CD49d/CD29, very late antigen-4, VLA-4) on circulating equine leukocytes and to evaluate the intrinsic potency of an alpha(4)beta(1) receptor...